RUSSELL FRANK CO/ - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 51 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$501,000
-39.1%
36,623
-16.3%
0.00%0.0%
Q4 2015$823,000
-2.1%
43,773
-2.3%
0.00%
-50.0%
Q3 2015$841,000
-41.4%
44,826
-60.6%
0.00%
-33.3%
Q3 2014$1,436,000113,8400.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders